Inquiry: The University of Arkansas Undergraduate Research
Journal
Volume 12

Article 9

Fall 2011

Sequence Analysis of the Angiotensin II Type 1 Receptor (AGTR1)
Gene for Mutations Contributing to Pulmonary Hypertension in
the Chicken (Gallus gallus)
John Russell Burks
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/inquiry
Part of the Animal Studies Commons, and the Poultry or Avian Science Commons

Recommended Citation
Burks, J. R. (2011). Sequence Analysis of the Angiotensin II Type 1 Receptor (AGTR1) Gene for Mutations
Contributing to Pulmonary Hypertension in the Chicken (Gallus gallus). Inquiry: The University of Arkansas
Undergraduate Research Journal, 12(1). Retrieved from https://scholarworks.uark.edu/inquiry/vol12/
iss1/9

This Article is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion
in Inquiry: The University of Arkansas Undergraduate Research Journal by an authorized editor of
ScholarWorks@UARK. For more information, please contact scholar@uark.edu.

Burks: Sequence Analysis of the Angiotensin II Type 1 Receptor (AGTR1) G

BIOLOGICAL SCIENCES: John Russell Burks  49
SEQUENCE ANALYSIS OF THE ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) GENE
FOR MUTATIONS CONTRIBUTING TO PULMONARY HYPERTENSION
IN THE CHICKEN (GALLUS GALLUS)
By John Russell Burks
Department of Biological Sciences
Faculty Mentor: Douglas Rhoads
Department of Biological Sciences
Abstract
Our multidisciplinary group at the University of Arkansas
has been investigating the suitability of the chicken as a medical
model for pulmonary arterial hypertension (PAH) in humans.
There are several forms of PAH in humans arising from elevated
pulmonary arterial pressure and pulmonary vascular resistance.
Spontaneous cases of PAH are known as idiopathic PAH (IPAH),
where the exact physiological causes are not known. IPAH patients
that do not respond to standard treatments have a prognosis of
only a few years. Currently, there is no acceptable animal model
for IPAH. As part of our effort to pursue the chicken as model
for IPAH, we have mapped chromosomal regions associated with
susceptibility to ascites, an industry term for PAH in chickens.
One region identified contains the angiotensin II type 1 receptor
gene (AGTR1), a gene known to be associated with particular
forms of PAH in humans. My project was to sequence the exonic
regions of AGTR1 from chickens selected for susceptibility and
resistance to ascites. I identified a total of 15 single nucleotide
polymorphisms (SNPs) in intronic regions and 9 affecting exonic
sequences that distinguish resistant and susceptible birds. One of
the SNPs alters the encoded protein, but more sequencing data
is needed to confirm the presence of this SNP. The 24 SNPs have
become the basis for further genotypic efforts using quantitative
polymerase chain reaction high-resolution melt (qPCR-HRM)
assays to determine the association of alternative alleles of
AGTR1 with PAH in the chicken. This knowledge will help the
poultry industry in genetic selection to reduce incidence of ascites.
Characterization of the genetic determinants of ascites in the
chicken will also identify specific gene networks and further our
understanding of PAH in humans.
Introduction
Pulmonary arterial hypertension (PAH) is currently accepted
as being classified into three main types: 1) idiopathic pulmonary
arterial hypertension (IPAH), 2) familial pulmonary arterial
hypertension (FPAH), and 3) pulmonary arterial hypertension
related to associated conditions or risk factors (APAH)
(Simmonneau et al., 2004). IPAH and FPAH have also been
classified as types of primary pulmonary hypertension, meaning
they have no known cause. APAH has been classified as secondary
pulmonary hypertension because the hypertension is believed to be
due to an underlying cause.
IPAH results in increases in pulmonary arterial pressure
and in pulmonary vascular resistance, which ultimately causes
Published by ScholarWorks@UARK, 2011

right ventricular failure and death if untreated or unresponsive
to treatment (Widlitz and Barst, 2003). The increased vascular
resistance in patients with pulmonary hypertension is due to
vasoconstriction, thrombosis in situ, and vascular remodeling
(Rubin, 1997). Primary pulmonary hypertension, including IPAH,
is defined as having a mean pulmonary artery pressure of 25
mmHg or greater at rest or 30 mmHg or greater during exercise,
with no related underlying condition (Widlitz and Barst, 2003).
IPAH is diagnosed in one to two new patients per million each
year, with an average survival of 2.5 years after initial diagnosis
(Rubin, 1997).
Adults with primary pulmonary hypertension generally
develop plexiform lesions and seemingly irreversible pulmonary
vascular changes (Widlitz & Barst, 2003). These vascular changes
are phenotypic changes in the endothelial and smooth muscle cells
in pulmonary arteries and are influenced by cell proliferation,
apoptosis, matrix proteins, and matrix turnover. Upregulation of
the transcription factor Oct-4 has been shown to be involved in
the irregular vasculature of the pulmonary arterial smooth muscle
cells in IPAH (Firth et al., 2010). Hemodynamic influences
are also important in the etiology of PAH. Additionally, gene
expression in pulmonary vascular cells is related to environmental
factors, receptors, growth factors, signaling pathways, and genetic
influences, all of which can interact with each other in the disease
process.
Serotonin metabolism has been shown to be central
to the etiology of PAH (MacLean, 2007). Serotonin
(5-hydroxytryptamine, 5HT) can be synthesized in the pulmonary
endothelium and released to either interact with serotonin cell
surface receptors or enter the smooth muscle cells via the serotonin
transporter (SERT). Serotonin can act to induce proliferation
and contraction of pulmonary smooth muscle cells through 5HT
receptors on the vascular epithelium. The actions of 5HT receptors
have been shown to be involved in PAH in humans (Humbert et
al., 2004).
The Renin-Angiotensin Aldosterone System (RAAS) is
a hormonal cascade that is important in the pathogenesis of
cardiovascular disorders (Atlas, 2007). The RAAS functions in
maintaining the homeostasis of arterial pressure, tissue perfusion,
and extracellular volume. The cascade begins with the secretion
of renin by the juxtaglomerular cells of the kidneys. In the
extracellular space, renin functions to cleave ten amino acids
from the N-terminus of angiotensinogen, which is constitutively
1
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secreted by the liver. The cleaved angiotensinogen is an inactive
ten amino acid peptide known as angiotensin I. Two amino
acids from the C-terminus of angiotensin I are cleaved by
membrane-bound angiotensin-converting enzyme (ACE), creating
the octapeptide, angiotensin II. Angiotensin II is the primary
biologically active product of the RAAS and acts as a potent
vasoconstrictor.
At least four types of angiotensin receptors have been
identified, but the type 1 receptor (angiotensin II type 1 receptor,
or AGTR1) is involved in most of the known physiology
of angiotensin II (Atlas, 2007). Cardiovascular effects of
angiotensin II and AGTR1 include vasoconstriction, increased
blood pressure, increased cardiac contractility, and vascular and
cardiac hypertrophy. Angiotensin II and AGTR1 have also been
shown to stimulate aldosterone synthesis by the adrenal cortex,
inhibit renin release, increase sodium reabsorption in the kidneys,
and affect the sympathetic nervous system. Angiotensin II and
AGTR1 also mediate effects on cell growth and proliferation,
inflammatory responses, and oxidative stress. AGTR1 contains
the seven transmembrane domains characteristic of the G proteincoupled receptor superfamily and is found on many cell types in
angiotensin II target organs.
The RAAS has been shown to be genetically involved in
human PAH (Chung et al., 2009). A specific polymorphism in the
angiotensin-converting enzyme (ACE) gene has been shown to be
associated with primary pulmonary hypertension (IPAH) and right
ventricular function (Abraham et al., 2003). Increased expression
of ACE has also been seen in the plexiform lesions of PAH (Orte
et al., 2000). Recent research has shown that certain variants of
AGTR1 are significantly related to PAH. Specifically, an adenine
(A)/cytosine (C) substitution at position 1166 in the 3’ untranslated
region of AGTR1 is significantly associated with early onset IPAH
in humans (Chung et al., 2009). This SNP occurs within a potential
target site for the miRNA-155, a microRNA (miRNA) binding site
(Ceolotto et al., 2011). They theorized that miRNA-155 can target
the 1166A allele, but not the 1166C allele. A study of hypertensive
subjects found that AGTR1 protein expression was negatively
correlated with miRNA-155 expression and that AGTR1 protein
expression was significantly greater in subjects homozygous
for the C allele than in heterozygous (CA) or homozygous A
subjects. This would be consistent with miRNA-155 repression
of the 1166A alleles and lack of repression of the 1166C SNP.
Overexpression of AGTR1 protein would then lead to higher blood
pressure.
Ascites, the industry term for PAH in chickens, results from
a fast growth rate and causes significant mortality in chickens
(Pavlidis et al., 2007). Ascites is among the most common and
most deadly cardiovascular conditions in modern lines of broiler
chickens (Olkowski, 2007). Increased genetic selection for fast
growth rate and the creation of diets that stimulate fast growth
contribute to the development of ascites in the broiler chicken
(Julian, 1993). Pulmonary hypertension in poultry causes right
ventricular hypertrophy, valvular insufficiency, increased venous
pressure, and ascites. Because the chicken heart has a thinwalled right ventricle and a muscular right atrioventricular valve,
pulmonary hypertension causes heart failure and death quickly in
https://scholarworks.uark.edu/inquiry/vol12/iss1/9

the chicken. Also, the broiler chicken is relatively small, but has
very large breasts, causing increased pressure on the air sacs of the
relatively small lungs.
The etiology of ascites in the broiler chicken begins with the
high basal metabolic rate required for fast growth (Government
of Alberta, 2008). Broilers are susceptible to ascites when their
pulmonary vascular capacity cannot tolerate the cardiac output
necessary for meeting the metabolic requirements of rapid growth,
which could be due to anatomical or functional restrictions
(Wideman et al., 2007). This inadequate capacity causes a deficit
in oxygen, which in turn causes the right ventricle to increase
the amount of blood pumped to the lungs to be oxygenated
(Government of Alberta, 2008). Because the right ventricle is thin
in the chicken, it often expands due to the increase in blood flow.
The increased blood flow causes increased pulmonary arterial
pressure and right ventricular hypertrophy. More red blood cells
are produced by the chicken to increase the oxygen carrying
capacity of the blood, but more red blood cells also cause the
blood to thicken and further increase vascular resistance. Valvular
insufficiency causes right ventricular failure and the associated
backflow causes liver edema, which leads to leakage of plasma
into the body cavity. This leads to an accumulation of fluid in
the abdomen (ascites). In the poultry industry the term is also
“water belly” and leads to either mortality or condemnation at the
plant. Ascites can be treated in the chicken with beta agonists and
dietary arginine, both of which increase ventilation and pulmonary
blood flow (Currie, 1999). Also, feed restriction is used to cause
a tachycardia that may protect birds from the brachycardia
associated with hypoxia-induced ascites.
There are several currently used animal models for human
pulmonary hypertension, with the most common being derived
from exposing the animal to chronic hypoxia or to monocrotaline
injury (Stenmark et al., 2009). Animals used include rats, mice,
piglets, calves, and macaques. Fawn-hooded rats are commonly
used because pulmonary hypertension manifests most severely in
these animals. However, none of these develops the plexogenic
arteriopathies found in humans and chickens. Our collaborative
group at the University of Arkansas is examining whether ascites
in the chicken (Gallus gallus) is a medical model for PAH/IPAH.
Ascites is easily induced in the chicken and lines of PAH resistant
and susceptible chickens have been developed. There are genetic
and pathophysiological similarities between ascites in the chicken
and PAH in the human. Chickens with ascites form plexogenic
arteriopathies that are indistinguishable from plexiform lesions
found in the lungs of humans with advanced PAH (Wideman et
al., 2011). Genetic evidence for the chicken being an appropriate
medical model for PAH can be found in our group’s identification
of chromosomal regions associated with ascites in the chicken
that contain genes that have been found to be involved in PAH in
humans (Chung et al., 2009; MacLean, 2007; Orte et al., 2000;
Smith, 2009).
A number of methods have been employed to induce PAH in
the chicken, including injection of bacterial lipopolysaccharide
(LPS), injection of micro-particles of cellulose, and exposure to
hypoxia to simulate high altitudes, such as growth in a hypobaric
chamber (Chapman et al., 2005; Currie, 1999; Pavlidis, 2007).
2
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Dr. Nicholas Anthony (University of Arkansas) has developed
divergently selected lines of broiler chickens that are resistant
(RES) or susceptible (SUS) to ascites using a hypobaric chamber
to induce the disease (Pavlidis, 2007). The chamber simulated
high altitude conditions via a partial vacuum to lower the partial
pressure of oxygen in the chamber. The RES and SUS lines were
created based on sib-selection over successive generations in the
hypobaric chamber.

are associated with susceptibility to PAH. As depicted in Figure
1, the chicken AGTR1 gene’s three exons are distributed across
20,979 bases (Gga 9: 13,475,625 – 13,496,603), with the entire
coding sequence located in exon 3 (International Chicken Genome
Sequencing Consortium, 2004). The three exons produce a final
mRNA transcript of 1427 bases. The first two exons are noncoding while the final exon encodes a predicted 359 amino acid
protein that is the receptor.

Our group then used a cross of the RES and SUS lines to
map several chromosomal segments contributing to PAH in the
chicken (Smith, 2009). One of those regions contains a serotonin
receptor-transporter (5HT receptor), which has been associated
with some forms of human PAH (MacLean, 2007). Another region
contained the ACE gene. Those genes are under investigation
by other students in the laboratory. A third region contains the
gene AGTR1, which is located on chromosome 9 and codes for
the angiotensin II type 1 receptor. As already mentioned, this
gene and the RAAS have been shown to be involved in PAH in
humans (Atlas, 2007; Chung et al., 2009). The implications of our
preliminary data is that mis-regulation of angiotensin II production
by ACE and the subsequent response by AGTR1 may be a
contributing factor for development of ascites.

Materials and Methods

Understanding the genetics of PAH in the chicken model will
identify specific gene networks and will advance understanding
of the underlying processes leading to PAH in humans. This
knowledge may also lead to genetic selection in the poultry
industry to lessen the economic losses associated with ascites.
The region containing the AGTR1 gene on chromosome
9 (Gga9) was previously associated with ascites in the chicken
through a whole genome association study and then confirmed
using variable number tandem repeat (VNTR) genotyping (Smith,
2009). Further research in our laboratory has associated this region
with ascites in our lines and in three commercial lines (Sriram
Krishnamoorthy, personal communication). Therefore, this region
appears to contain a major determinant of ascites susceptibility in
chickens. A region in the human genome that contains the AGTR1
gene has been associated with some forms of PAH, thus it is likely
that mutations affecting the AGTR1 gene could contribute to
ascites in chickens.

DNA Isolation
DNAs were previously isolated by Sriram Krishnamooorthy,
Ph.D. candidate University of Arkansas, from chickens that were
then phenotyped in a hypobaric chamber. These DNAs have
been previously validated by others in our laboratory for PCR
amplification of numerous regions.
Primer Design for Polymerase Chain Reaction (PCR)
The genomic region representing AGTR1 was downloaded
from the UCSC genome browser. Primer3 (http://frodo.wi.mit.edu/
primer3/) was used to design oligonucleotide primers covering
all of the exonic regions. Primers were synthesized by EurofinsOperon. PCR conditions were then optimized for primer pairs.
Polymerase Chain Reaction (PCR)
PCR mixtures were assembled incorporating H2O, PCR
Buffer, deoxyribonucleotide triphosphate (dNTPs), Taq
polymerase, primers, and target DNA. Twenty µl PCR mixtures
contained 1X PCR Buffer (50 mM TrisCl, 1 mM MgCl2, 3 mg/
ml BSA), 0.2 mM dNTPs, 3 units Taq polymerase, 2 µl target
DNA, and 1 µM forward and reverse primer mixture. Reactions
for sequencing consisted of 200 µl of the same concentrations of
1X PCR Buffer, 0.2 mM dNTPs, 1 µM forward and reverse primer
mixture, but differed by using 10 units Taq polymerase, and 5 µl
target DNA. Reactions were cycled in one of four PCR machines
in our laboratory to obtain amplicons of the three exons of AGTR1
in the resistant and susceptible birds.
Gel Electrophoresis for Quality of PCR Product

A portion of the PCR product was resolved on a 1.5% agarose
gel to evaluate the quality of the product. Five µl of PCR product
was mixed with 5 µl of loading dye prior to loading into gel. The
My research project was to sequence the AGTR1 gene from
Figures
loading dye used was 10 µg/ml ethidium bromide (EthBr), 15%
the resistant and susceptible lines to determine whether mutations
Ficoll, 20mM EDTA, 0.1% Bromophenol Blue 0.1% Xylene
could be found that represent alternative alleles of AGTR1. I then
Molecular weight ladder was pGEM5 digested with
Cyanol.
developed qPCR-HRM assays for the alternative alleles of AGTR1
Sau3A.
Gels
were submerged in 0.5X TBE with 0.5 µg/ml EthBr
for use in genotyping a larger collection of DNAs. Additional
and
electrophoresed
for9approximately
5-10
minutes Genome
at 40 Volts
Figure 1:
UCSC
genome
browser
view
of
the
chicken
AGTR1
gene
on
chromosome
(International
Chicken
genotype data will determine whether these particular mutations

Sequencing Consortium, 2004). http://genome.ucsc.edu.

Figure 1: UCSC genome browser view of the chicken AGTR1 gene on chromosome 9 (International Chicken Genome Sequencing Consortium, 2004).
http://genome.ucsc.edu.
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(V) and then for approximately 90 minutes at 70 V.
Gel Imaging
Gels were imaged either using an Ultraviolet Transilluminator
captured with a CCD camera and FlashPoint FPG software, or the
gels were scanned at 600nm using a Model 9600 Typhoon Imager
(GE HealthCare) and analyzed with ImageQuant Software.
Purification and Quantification of PCR product
To purify DNA samples for sequencing, reactions were diluted
1x with TE (10 mM TrisCl, 1 mM EDTA, pH 7.5) and extracted
with phenol:chloroform:isoamyl alcohol (50:48:2) and then with
chloroform:isoamyl alcohol (24:1). The solution was brought to
0.3 M with sodium acetate and DNA precipitated by addition of 3
volumes of 95% ethanol. The mixture was incubated at -20°C for
1-2 hours and then DNAs were collected by centrifugation (10 min
at 10,000 rpm). The pellet was rinsed with cold 70% ethanol, dried
under vacuum and redissolved in 10 mM TrisCl, 0.1 mM EDTA.
DNA was quantified using a Model TKO 100 Hoefer Scientific
Instruments DNA Fluorometer according to the manufacturer’s
instructions.
DNA Sequencing and Analysis
Purified PCR products (5-20 ng) were mixed with 3.4 pM
of individual primers, and submitted to the UA DNA Resource
Center for capillary sequencing. The sequence files were aligned
using Seqman software from DNAStar.
Quantitative PCR – High Resolution Melt (qPCR-HRM)
Assays for SNPlotyping
Primers were designed that flank single nucleotide
polymorphisms (SNPs) to generate a short amplicon (generally
less than 60 base pairs). The oligonucleotide primers were
designed using Primer3 (http://frodo.wi.mit.edu/primer3/) and
were synthesized by Eurofins-Operon.
Twenty µl PCR reactions each contained 1X PCR Buffer
(50 mM TrisCl, 1 mM MgCl2, 3 mg/ml BSA), 0.2 mM dNTPs, 3
units Taq polymerase, 1 µl target DNA, 1 µM forward and reverse
primer mixture, H2O, and an intercalating dye (SYBR Green,
LCGreen, or EvaGreen). The qPCR-HRM assay was performed
on a BioRad CFX96 Real-Time System. The protocol used
included the following steps: 1) 95°C for 30 seconds, 2) 95°C for
15 seconds, 3) 50°C for 15 seconds, 4) 72°C for 30 seconds and
plate read, 5) Repeat steps 2-4 39 times, 6) 72°C for 3 minutes, 7)
95°C for 3 minutes, 8) 65°C for 3 minutes, and 9) Gradient from
65°C-90°C at 0.1°C increments for 10 seconds with plate read at
each increment.
Results
I designed four pairs of oligonucleotide primers that amplify
the three exonic regions of the AGTR1 gene. The size of exon
3 required the use of two pairs of primers, while exons 1 and
2 required one pair each. Two additional pairs of primers were
designed to flank exon 3 because the original pair flanking one
portion of exon 3 produced no PCR product. All primers were
optimized for annealing temperatures and cycling conditions using
chicken genomic DNA. The primer pair names, sequences, and
optimized PCR conditions are shown in Tables 1 and 2.
https://scholarworks.uark.edu/inquiry/vol12/iss1/9

The primer pair for exon 1 (AGTR1 X1 F1/R1) was optimized
for 20 µl PCRs but no product was obtained when a 200 µl PCR
was performed for sequencing. The AGTR1 X3-2 F1/R1 primer
pair did not produce a PCR product.
Quality amplicons of exons 2 and 3 were obtained from
200 µl PCR reactions, purified, and sequenced. Sequences
were obtained from two of the three AGTR1 exonic regions
from several resistant and susceptible birds (usually 3 of each).
The sequences were aligned with the AGTR1 gene from the
2006 genome assembly of the Red Jungle Fowl (Gallus gallus)
sequence. The alignments for exon 2 and exon 3 are presented in
Figures 2 and 3, respectively.
Comparisons between Jungle Fowl, resistant, and susceptible
sequences identified 24 single nucleotide polymorphisms (SNPs),
four of which affected the AGTR1 coding sequence. All identified
SNPs are listed in Table 3. Fourteen SNPs were found in the
intronic sequence 5’ of exon 2 and three SNPs were found within
exon 2. One SNP was found in the intronic sequence 5’ of exon
3. Six SNPs were identified in exon 3 including one SNP in the 3’
untranslated region (UTR).
Five pairs of primers were designed to amplify specific SNPs
in exons 2 and 3 for high resolution melt analyses. Two primers
designed to amplify regions containing SNPs were optimized
using genomic chicken DNA and are ready to be used in a
SNPlotyping application. Three of the five primer pairs designed
to amplify the SNP regions were not optimized.
A LCGreen qPCR-HRM assay to SNPlotype multiple resistant
and susceptible chickens was completed for the SNP located at
base 2513. The AGTR1_2513F/R primer pair was used and the
melt curve is shown in Figure 4.
Discussion
Several polymorphisms were identified that establish that
there are at least two forms of the AGTR1 gene in our RES and
SUS lines (Pavlidis, 2007). The 14 SNPs found in the intronic
region 5’ of exon 2 and the three SNPs in exon 2 do not affect
the coding region for the AGTR1 protein, as these SNPs are in
non-coding regions. Two SNPs, one in the intronic region 5’ of
exon 3 and one in exon 3, need more sequence from additional
chickens for confirmation. Sequence data was only obtained from
two individuals, both resistant, for each of these two SNPs. The
intronic SNP would have no effect on the protein sequence, but
the SNP in exon 3 is in the first position of a proline codon at
position 82 of the protein (Pro82) and would change the encoded
amino acid to serine. Proline residues are normally considered as
disrupters of secondary structure. This proline is located within the
extracellular portion of the alpha helical transmembrane II domain
(G Protein-Coupled Receptor Database, 2011). Because of its
location outside of the hydrophobic membrane, replacement of the
proline with a hydrophilic serine would not alter the hydrophilicity
of the region but certainly could alter a secondary structure. Pro82
is highly conserved in human, cow, mouse, rat, opossum, lizard,
frog, and zebrafish (See Figure 5). Four other SNPs found in exon
3 are located in the third codon position (i.e., the wobble position)
and would be silent with respect to the encoded protein. The
specific codon changes are shown in Table 3.
4
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AGTR1 X1 F1/R1
AGTR1 X2 F1/R1
AGTR1 X3-1 F1/R1
AGTR1 X3-2 F1/R1
AGTR1 X3-1 F2/R2
AGTR1 X3-2 F2/R2
AGTR1_2228_2235 F/R
AGTR1_2513 F/R
AGTR1_21618 F/R
AGTR1_21945 F/R
AGTR1_22050 F/R

Primer Name

Step 3:
Annealing
55°C, 20s
53°C, 20s
50°C, 20s
50°C, 20s

50°C, 15s
50°C, 15s

90°C, 15s
90°C, 15s

72°C, 30s
72°C, 30s

Step 4:
Extension
72°C, 2min
72°C, 2min
72°C, 2min
72°C, 2min

gtcacgcacactcccttagcaa
tcaaaaatcaccgaaggcagtg
gcagattaattgccgactattcca
TCACGAATCCGACGTACCATGT
gtgcccacaatccagttttc
CTTGCTGGTGTGGCCAGT
gtattcttccaagcaaatcc
aaaaggactttttgtctatttgga
GCCCGTCATCATTCATCG
CATGTAATAACAGACTGCAAAAT
TTTTTATGTTTTCTTTGGAA

Forward Sequence (5' - 3')

Step 2:
Denaturation
90°C, 20s
90°C, 20s
90°C, 20s
90°C, 20s

Fragment
Length (bp)
808
844
785
760
836
697
50
50
50
52
59

Step 1: Initial
Denaturation
90°C, 60s
90°C, 60s
90°C, 60s
90°C, 60s
Not Optimized
Not Optimized
90°C, 30s
90°C, 30s
Not Optimized
Not Optimized
Not Optimized

AGTR1 X1 F1/R1
AGTR1 X2 F1/R1
AGTR1 X3-1 F1/R1
AGTR1 X3-2 F1/R1
AGTR1 X3-1 F2/R2
AGTR1 X3-2 F2/R2
AGTR1_2228_2235 F/R
AGTR1_2513 F/R
AGTR1_21618 F/R
AGTR1_21945 F/R
AGTR1_22050 F/R

Table 2: Optimized PCR conditions for primer pairs.

Exon 1
Exon 2
Exon 3-1
Exon 3-2
Exon 3-1
Exon 3-2
Intron Indel/SNP
Exon 2 SNP
Exon 3 SNP
Exon 3 SNP
Exon 3 SNP

Amplified Region Primer Pair Name

44
44

Number of Cycles
(repeat steps 2-4)
40
40
40
40

72°C, 3min
72°C, 3min

Step 5: Final
Extension
72°C, 3min
72°C, 3min
72°C, 3min
72°C, 3min

ggtccttcctctgccaacttca
caacaagcaaaagggactgacg
AAAGCCACAGACCGTCATGTTC
gatgtctgggactgcagatgga
CCACAGACCGTCATGTTCAA
ctgggactgcagatggattt
agtgcttgtccataccatga
AGTCCCCTCTTCTCCTGCTC
TCATGTTCAAGTTCTCTGCAAAA
AGGGCATAGCTGTATCCACAA
TGTATTTTATTAGCTGAAGGAAG

Reverse Sequence (5' - 3')

Table 1: Primer information. Sequence in capital letters indicate exonic sequences, with lowercase for intronic sequences. Numbers in SNP primer pair names correspond to the base pair location of the SNP in
the mRNA for exonic SNPs and relative to the transcription start site in the gene for intronic SNPs.
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Figure 2: AGTR1 SNPs in the intronic region 5’ of exon 2 and in exon 2. (R) denotes PAH-resistant birds and (S) denotes PAH-susceptible birds. Sequences are aligned with the 2006 Red Jungle Fowl sequence
assembly (International Chicken Genome Sequencing Consortium, 2004).

Intronic region 5’ of exon 2:

Figure 2: AGTR1 SNPs in the intronic region 5’ of exon 2 and in exon 2. (R) denotes PAH-resistant birds and (S) denotes PAH-susceptible birds. Sequences are aligned with the 2006 Red Jungle Fowl sequence assembly
(International Chicken Genome Sequencing Consortium, 2004).
).
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UTR 3’ of exon 3:

Figure 3: AGTR1 SNPs in the intronic region 5’ of exon 3, in exon 3, and in the UTR 3’ of exon 3. (R) denotes PAH-resistant birds and (S) denotes PAH-susceptible birds. Sequences are aligned with the 2006 Red
Jungle Fowl sequence assembly (International Chicken Genome Sequencing Consortium, 2004). Sequence within the coding region of exon 3 is shown with the associated protein sequence (bottom reading frame).

Exon 3:

IIntronic region 5’ of exon 3:
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Table 3: SNP Information. Jungle Fowl genotype was obtained from the 2006 assembly of Red Jungle Fowl (Gallus gallus)
(International Chicken Genome Sequencing Consortium, 2004). Codon Change is relative to the Jungle Fowl sequence. *More
Table 3: SNP Information. Jungle Fowl genotype was obtained from the 2006 assembly of Red Jungle Fowl (Gallus gallus) (International Chicken Genome
sequenceConsortium,
data is needed
confirm.
Sequencing
2004). to
Codon
Change is relative to the Jungle Fowl sequence. *More sequence data is needed to confirm.
SNP Region

Locus (bp)

Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
Intronic region 5' of exon 2
First base of exon 2
Exon 2
Exon 2
*Intronic region 5' of exon 3
*Exon 3
Exon 3
Exon 3
Exon 3
Exon 3
UTR 3' of exon 3

1996
2011
2114
2180
2190
2228
2235
2413
2418
2422
2423
2425
2448
2503
2513
2608
2687
20991
21361
21618
21945
21987
22050
22210

Jungle Fowl
Resistant
Genotype
Genotype(s)
CC
CC
TT
TT
GG
AA
GG
AA
CC
TT
No Base
AA
AA
AA
GG
GG
GG
GG
CC
CC
AA
AA
TT
TT
TT
TT
CC
CC
GG
AA
No Base
TT
No Base
No Base
AA
TT
CC
C/T
TT
TT
CC
CC
CC
TT
AA
GG
TT
CC

The SNP found in the 3’ UTR of exon 3 was not found to be
analogous to the 3’ UTR SNP found to be associated with PAH by
Chung et al (2009). The SNP in the human AGTR1 gene was 86
bases 3’ to the terminator codon, but the SNP found in the chicken
was 13 bases 3’ to the stop codon. However, this SNP may still be
of importance in terms of its potential effects on miRNA binding
sites. There are several miRNA binding sites located in the 3’
UTRs of the human AGTR1 mRNA, so SNPs located in one of
these binding sites could have an effect on miRNA function and
gene expression (Elton et al., 2010). Perhaps the SNP found in
the 3’ UTR of the chicken is localized in a miRNA binding site or
creates a novel miRNA binding site, both of which could affect
miRNA function and gene expression.
New primers may need to be designed to amplify exon
3 and three of the SNP regions, while a different strategy or
primer redesign may be necessary to obtain sequence for exon
1. Sequence data needs to be obtained for exon 1 and additional
sequence data is needed for the first portion of exon 3. Also, more
work can be done to determine whether any particular AGTR1
allele is associated with PAH susceptibility. One approach used
in our laboratory is the development of qPCR-HRM (quantitative
PCR High-Resolution Melt) assays for SNPlotyping a collection
of DNAs representing different susceptible and resistant lines.
Two of the five SNP primers I designed are ready for this analysis,
whereas three others need further optimization or need to be
redesigned. Statistical analysis of the frequency of each SNPlotype
can be performed to determine whether there is an association of
any of these SNPs with ascites phenotype. In addition, based on
https://scholarworks.uark.edu/inquiry/vol12/iss1/9

Susceptible
Genotype(s)
TT
CC, C/T
GG, G/A
GG, G/A
CC, C/T
AA
TT, A/T
AA, A/G
TT, G/T
TT, C/T
GG, G/A
AA, A/T
GG, G/T
TT, C/T
GG, G/A
No Base
GG
No Data
No Data
CC, C/T
TT, C/T
CC, C/T
AA, A/G
TT, C/T

Codon Change
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
CCA (Pro) to TCA (Ser)
CGT (Arg) to CGC (Arg)
ATC (Ile) to ATT (Ile)
ATT (Ile) to ATC (Ile)
AAA (Lys) to AAG (Lys)
N/A

frequencies and concordance, it can be determined which SNPs
are in linkage and define different particular haplotypes (alleles)
for AGTR1.
The melt curve obtained from a qPCR-HRM assay for
the SNP located at base 2513 showed insufficient allelic
discrimination (data not shown). That is, the melting temperatures
were not significantly different between the resistant and
susceptible chickens so as to determine that there are or are not
two alleles. Additional analysis using qPCR-HRM assays are
being pursued to examine additional SNPs identified in AGTR1.
A Ph.D. candidate in the lab is currently using qPCR
on cDNA to study expression levels of AGTR1 in different
tissues from resistant and susceptible chickens. He has detected
significant differences in expression of AGTR1 in RNA from
whole blood. With qPCR-HRM assays we should be able to
correlate expression levels with particular alleles to determine
whether the allelic effect is associated with differences in
expression or the protein product.
Further genetic analysis of the different forms of the AGTR1
gene from both susceptible and resistant birds will lead to insight
into how particular mutations in the gene may contribute to the
development of ascites in the chicken. It is this knowledge of the
genetics of ascites in chickens that will lead to genetic selection
to reduce ascites in chickens, and further develop the chicken as
a medical model for PAH in humans. Availability of an animal
medical model will provide the means to develop and evaluate
new treatments for PAH in humans.
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Figure 4. Melt Curve for SNP at base 2513. The peaks represent melting temperatures of each sample. There is insufficient
discrimination between RES and SUS chickens to determine if two alleles are or are not present.
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Figure 5. Alignment of AGTR1 proteins from selected vertebrates. The region of AGTR1 from residue 66 to 115 (based on G.
gallus)
are
forfor
theSNP
indicated
organisms.
were extracted
from GenBank
and aligned
at
Figure
4. shown
Melt Curve
at base 2513.
The peaksProtein
representsequences
melting temperatures
of each sample.
There is insufficient
discrimination
between RES and
http://www.ncbi.nlm.nih.gov/tools/cobalt/cobalt.cgi.
proline
residue
by present.
the SNP is underlined and bold (see text).
SUS chickens toThe
determine
if two
allelesaffected
are or are not

Human
Chimpanzee
Cow
Mouse
Rat
Opossum
Lizard
Frog
Zebrafish
G.gallus

FLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYAS
FLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYAS
FLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYAS
FLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNHLCKIASASVSFNLYAS
FLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNHLCKIASASVSFNLYAS
FLLNLALADLCFLMTLPLWAAYTAMEYRWPFGNCLCKIASAGISFNLYAS
FLFNLALADLCFIVTLPLWAATTAMEYRWPFGNCLCKLTSAAASFNLYAS
FLMNLALSDLCFVITLPLWAVYTAMHYHWPFGDLLCKIASTAITLNLYTT
YIGNLALADLTFVITLPLWAVYTALGYHWPFGVALCKISSYVVLVNMYAS
FLLNLALADLCFLITLPLWAAYTAMEYQWPFGNCLCKLASAGISFNLYAS

Figure 5. Alignment of AGTR1 proteins from selected vertebrates. The region of AGTR1 from residue 66 to 115 (based on G. gallus) are
shown for the indicated organisms. Protein sequences were extracted from GenBank and aligned at
http://www.ncbi.nlm.nih.gov/tools/cobalt/cobalt.cgi. The proline residue affected by the SNP is underlined and bold (see text).
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Mentor Comments: Dr. Rhoads’ comments place Russell’s work
into the larger context of a major interdisciplinary research initiative that showcases some of the most exciting work taking place
on the University of Arkansas campus.
Russell Burks’ sequence analyses of the AGTR1 gene is part
of a collaborative project between several research groups on
the University of Arkansas campus investigating Pulmonary
Arteriole Hypertension (PAH) in the chicken. PAH results in a
disease known as Ascites in the poultry industry with annual
costs estimated at over $100,000,000. During the past 15
years, Dr. Nicholas Anthony in Poultry Science developed
ascites susceptible and ascites resistant lines of chickens. We
then collaborated on mapping the gene regions contributing
to ascites phenotype. One gene region contained the AGTR1
gene which, in humans, has been implicated in some forms of
PAH. Sriram Krishnamoorthy (Ph.D. student in Dr. Anthony’s
group) has confirmed that the region of AGTR1 is associated
with Ascites phenotype in the experimental lines and in
commercial lines.
Therefore, Russell took on the task of sequencing the AGTR1
gene from the resistant and susceptible lines. He used PCR to
amplify the exonic regions from multiple chickens. Sequences
of those regions revealed a number of single nucleotide
polymorphisms (SNPs). Some of these SNPs are not in exons,
while a few affect exonic sequences including one that would
alter the AGTR1 protein. Although none of these SNPs may be
the actual mutation that contributes to ascites susceptibility/
resistance, they are excellent markers for investigating this
region further. AGTR1 is part of the angiontensin pathway
which regulates vasoconstriction and kidney function. Dr.
Robert Wideman (Poultry Science) and Dr. Heidi Kluess
(Health Science, Kinesiology, Recreation and Dance) have
been investigating the pharmacology of vasoconstriction
in lung arterioles of the chicken. Adnan Al-Rubaye (Ph.D.
student in my laboratory) is investigating the expression
levels of AGTR1 in different tissues from resistant and
susceptible chickens. Therefore, Russell’s contribution is a set
of molecular tools that will allow us to correlate particular
AGTR1 alleles with gene expression levels, physiological
responses, and prediction of ascites phenotype.
What is truly exciting about this is that the research at the
University of Arkansas has been demonstrating that the
chicken may very well be one of the best medical models
for PAH in humans. The AGTR1 work is part of that and
demonstrates that the chicken has many of the same
underlying physiological and genetic bases for PAH as found
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in humans. Thus, we are not only going to understand the
disease to minimize the impact on the poultry industry, but
may also develop an excellent model for understanding and
developing new treatments for the disease in humans.
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